183 related articles for article (PubMed ID: 25670042)
1. VEGF-D and A Preoperative Serum Levels Predict Nodal and Distant Metastases in Differentiated Thyroid Cancer Patients.
Lai CW; Duh QY; Chen CW; Chuang FJ; Chang YJ; Lin MT; Wu MH
World J Surg; 2015 Jul; 39(7):1742-9. PubMed ID: 25670042
[TBL] [Abstract][Full Text] [Related]
2. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Leung P; Luk JM
Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194
[TBL] [Abstract][Full Text] [Related]
3. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.
Tuttle RM; Fleisher M; Francis GL; Robbins RJ
J Clin Endocrinol Metab; 2002 Apr; 87(4):1737-42. PubMed ID: 11932308
[TBL] [Abstract][Full Text] [Related]
4. Serum vascular endothelial growth factor-D levels correlate with cervical lymph node metastases in papillary thyroid carcinoma.
Lai CW; Chen KY; Hung CS; Kuo SW; Chang YJ; Lin MT; Chang KC; Wu MH
Growth Factors; 2011 Apr; 29(2-3):57-62. PubMed ID: 21319951
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G
J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080
[TBL] [Abstract][Full Text] [Related]
6. VEGFR1 expression is related to lymph node metastasis and serum VEGF may be a marker of progression in the follow-up of patients with differentiated thyroid carcinoma.
Karaca Z; Tanriverdi F; Unluhizarci K; Ozturk F; Gokahmetoglu S; Elbuken G; Cakir I; Bayram F; Kelestimur F
Eur J Endocrinol; 2011 Feb; 164(2):277-84. PubMed ID: 21097568
[TBL] [Abstract][Full Text] [Related]
7. Lymph nodes metastases in differentiated thyroid cancer--prognostic value and surgical results with 430 patients for 30 years period (1980-2010).
Petkov R; Katev N; Todorov G; Mladenovski V; Yaramov N; Sokolov M
Khirurgiia (Sofiia); 2011; (1):5-11. PubMed ID: 23847796
[TBL] [Abstract][Full Text] [Related]
8. Predicting lymph node metastasis in patients with papillary thyroid carcinoma by vascular index on power Doppler ultrasound.
Lee JH; Shin HJ; Yoon JH; Kim EK; Moon HJ; Lee HS; Kwon HJ; Kwak JY
Head Neck; 2017 Feb; 39(2):334-340. PubMed ID: 27704649
[TBL] [Abstract][Full Text] [Related]
9. [The significance of lymph node status in papillary and follicular thyroid gland carcinoma for the nuclear medicine physician].
Farahati J; Mörtl M; Reiners C
Zentralbl Chir; 2000; 125(10):830-4. PubMed ID: 11098578
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors associated with differentiated thyroid cancer.
Tsuchiya A; Suzuki S; Kanno M; Kikuchi Y; Ando Y; Abe R
Surg Today; 1995; 25(9):778-82. PubMed ID: 8555694
[TBL] [Abstract][Full Text] [Related]
12. [Lymph node dissection in non-medullary differentiated thyroid carcinoma].
Mathonnet M
Ann Chir; 2006; 131(6-7):361-8. PubMed ID: 16329987
[TBL] [Abstract][Full Text] [Related]
13. Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer.
Lin SY; Wang YY; Sheu WH
Clin Endocrinol (Oxf); 2003 Apr; 58(4):513-8. PubMed ID: 12641636
[TBL] [Abstract][Full Text] [Related]
14. [Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].
Witte J; Schlotmann U; Simon D; Dotzenrath C; Ohmann C; Goretzki PE
Zentralbl Chir; 1997; 122(4):259-65. PubMed ID: 9221636
[TBL] [Abstract][Full Text] [Related]
15. Surgical management of cervical lymph nodes in differentiated thyroid cancer.
Fritze D; Doherty GM
Otolaryngol Clin North Am; 2010 Apr; 43(2):285-300, viii. PubMed ID: 20510715
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.
Mercante G; Frasoldati A; Pedroni C; Formisano D; Renna L; Piana S; Gardini G; Valcavi R; Barbieri V
Thyroid; 2009 Jul; 19(7):707-16. PubMed ID: 19348581
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factors and angiopoietins in presentations and prognosis of papillary thyroid carcinoma.
Hsueh C; Lin JD; Wu IC; Chao TC; Yu JS; Liou MJ; Yeh CJ
J Surg Oncol; 2011 Apr; 103(5):395-9. PubMed ID: 21400522
[TBL] [Abstract][Full Text] [Related]
18. Serum soluble interleukin 2 (IL-2) receptor (sIL-2R) in differentiated thyroid carcinoma.
Mariotti S; Barbesino G; Caturegli P; Marinò M; Manetti L; Fugazzola L; Pacini F; Pinchera A
J Endocrinol Invest; 1994 Dec; 17(11):861-7. PubMed ID: 7745234
[TBL] [Abstract][Full Text] [Related]
19. Practical Initial Risk Stratification Based on Lymph Node Metastases in Pediatric and Adolescent Differentiated Thyroid Cancer.
Jeon MJ; Kim YN; Sung TY; Hong SJ; Cho YY; Kim TY; Shong YK; Kim WB; Kim SW; Chung JH; Kim TH; Kim WG
Thyroid; 2018 Feb; 28(2):193-200. PubMed ID: 29179646
[TBL] [Abstract][Full Text] [Related]
20. Recurrent differentiated thyroid cancer without elevation of serum thyroglobulin.
Westbury C; Vini L; Fisher C; Harmer C
Thyroid; 2000 Feb; 10(2):171-6. PubMed ID: 10718555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
